Laparoscopic tube-preserving surgical procedures for ectopic tubal pregnancy
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
ObjectiveTo present our experience with laparoscopic tube-preserving surgery for ectopic tubal pregnancy and evaluate its feasibility and efficacy. MethodsThis was a prospective study of 57 consecutive patients with ectopic tubal pregnancies undergoing laparoscopic tube-preserving procedures including salpingotomy, salpingostomy, segmental resection and reanastomosis, and fimbrial milking. The outcome measures were treatment success rates and homolateral patency rates. ResultsOf the 57 surgical procedures, 55 (96.4%) were performed successfully without any additional intervention. The number of patients receiving salpingotomy, salpingostomy, segmental resection and reanastomosis, and fimbrial milking were 24 (42.1%), 25 (43.9%), 4 (7.0%), and 2 (3.5%), respectively. Two case was switched to salpingectomy because excessive bipolar coagulation was required to obtain hemostasis at the tubal bleeding bed. Over a mean β-human chorionic gonadotropin resolution time of 18.3±5.9 days, no persistent trophoblast or postoperative complications occurred. A tubal patency test using hysterosalpingography was performed in 15 cases at 3 months postoperatively. Among these, the homolateral tubal patency rate was 75% (11 of 15) and the contralateral patency rate was 80% (12 of 15). ConclusionTube-preserving surgery is a feasible and safe treatment option for ectopic tubal pregnancy. However, considering that the optimal goal of tube-preserving surgical procedures is not the treatment success, some caution is warranted in interpreting results of this study.
Abstract
ObjectiveTo evaluate the effect of orally administered dienogest (DNG) for dysmenorrhea and pelvic pain associated with endometriosis. MethodsFor this study we recruited 89 patients with dysmenorrhea and pelvic pain associated with endometriosis diagnosed by laparoscopy. All patients complained of persistent dysmenorrhea and pelvic pain despite surgical treatment 6 months previously. After 6 months of DNG treatment, we used a 0 to 3 point verbal rating scale to measure the severity of disability in daily life due to dysmenorrhea and pelvic pain, and the use of analgesics. Weight gain, serum lipid and liver enzyme tests were performed before treatment and after 6 months of DNG treatment. ResultsTotal dysmenorrhea scores assessed by the verbal rating scale significantly decreased by the end of treatment (P<0.001). The mean (±standard deviation) pain score for dysmenorrhea before and after treatment were 1.42±1.1 and 0.1±0.3, respectively. The mean non-menstrual pelvic pain scores before and after treatment were 0.52±0.6 and 0.18±0.3, respectively, showing a significant difference (P<0.001). The use of analgesics significantly decreased by the end of the treatment (P<0.001). The associated adverse effects were weight gains (in 56 of 89 patients, 63%) and uterine bleeding (in 28 of 89 patients, 31.5%). The weight gain (before treatment, 57.9±9.7; after treatment, 61.1±12.6) was statistically significant (P<0.040). ConclusionThis study demonstrated that orally administered DNG could be used to effectively treat dysmenorrhea and pelvic pain associated with endometriosis although the side effects of weight gain and uterine bleeding should be considered.
참고문헌 (18)
- Walker JJ, "Ectopic pregnancy", Clin Obstet Gynecol, 50, pp.89~99 (2007)
- Al-Sunaidi M, "Surgical treatment of ectopic pregnancy", Semin Reprod Med, 25, pp.117~122 (2007)
- Farquhar CM, "Ectopic pregnancy", Lancet, 366, pp.583~591 (2005)
- Fylstra DL, "Operative obstetrics", pp.355~378 (2002), McGraw-Hill
- Hajenius PJ, "Interventions for tubal ectopic pregnancy", Cochrane Database Syst Rev, (1) (2007)
- Yao M, "Current status of surgical and nonsurgical management of ectopic pregnancy", Fertil Steril, 67, pp.421~433 (1997)
- Mol F, "Current evidence on surgery, systemic methotrexate and expectant management in the treatment of tubal ectopic pregnancy: a systematic review and meta-analysis", Hum Reprod Update, 14, pp.309~319 (2008)
- Alkatout I, "Clinical diagnosis and treatment of ectopic pregnancy", Obstet Gynecol Surv, 68, pp.571~581 (2013)
- DeCherney AH, "Isthmic ectopic pregnancy : segmental resection as the treatment of choice", Fertil Steril, 44, pp.307~312 (1985)
- van Mello NM, "Salpingotomy or salpingectomy in tubal ectopic pregnancy: what do women prefer?", Reprod Biomed Online, 21, pp.687~693 (2010)
- Elmoghazy DA, "Prevention of persistent ectopic pregnancy with single dose methotrexate after surgical conservation of the tube", Int J Gynecol Obstet, 70, pp.B57~ (2000)
- Gracia CR, "Prophylactic methotrexate after linear salpingostomy : a decision analysis", Fertil Steril, 76, pp.1191~1195 (2001)
- Graczykowski JW, "Methotrexate prophylaxis for persistent ectopic pregnancy after conservative treatment by salpingostomy", Obstet Gynecol, 89, pp.118~122 (1997)
- Hajenius PJ, "Clearance curves of serum human chorionic gonadotrophin for the diagnosis of persistent trophoblast", Hum Reprod, 10, pp.683~687 (1995)
- Song T, "Laparoscopic salpingotomy using the floseal hemostatic sealant in patients with tubal pregnancy", J Laparoendosc Adv Surg Tech A, 24, pp.651~655 (2014)
- Seifer DB, "Persistent ectopic pregnancy", Obstet Gynecol Clin North Am, 18, pp.153~159 (1991)
- Hajenius PJ, "Randomised trial of systemic methotrexate versus laparoscopic salpingostomy in tubal pregnancy", Lancet, 350, pp.774~779 (1997)
- Fujishita A, "Laparoscopic salpingotomy for tubal pregnancy : comparison of linear salpingotomy with and without suturing", Hum Reprod, 19, pp.1195~1200 (2004)